STOCK TITAN

IQVIA (IQV) EVP Bernd Haas discloses common stock and SAR awards

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
3

Rhea-AI Filing Summary

IQVIA Holdings executive Bernd Haas, EVP of AI and Technology Solutions, reported his initial holdings of the company’s equity. He directly beneficially owns 16,589 shares of IQVIA common stock, which include restricted stock units that are scheduled to vest on February 13, 2026 and January 28, 2028. He also holds multiple stock appreciation rights over IQVIA common stock, with grants covering share amounts such as 2,781, 4,032 and 8,778, and exercise prices ranging from $95.23 to $250.43, expiring between 2028 and 2035. Several of these awards have portions already vested, with the remaining parts set to vest in annual installments beginning in 2026.

Positive

  • None.

Negative

  • None.
SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Haas Bernd

(Last) (First) (Middle)
C/O IQVIA HOLDINGS INC.
2400 ELLIS ROAD

(Street)
DURHAM NC 27703

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
12/31/2025
3. Issuer Name and Ticker or Trading Symbol
IQVIA HOLDINGS INC. [ IQV ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
See Remarks
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 16,589(1) D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Appreciation Right 02/08/2021 02/08/2028 Common Stock 2,781 $95.23 D
Stock Appreciation Right 02/13/2022 02/13/2029 Common Stock 1,843 $131.82 D
Stock Appreciation Right 02/11/2023 02/11/2030 Common Stock 4,032 $161.7 D
Stock Appreciation Right 02/09/2024 02/09/2031 Common Stock 1,869 $183.82 D
Stock Appreciation Right 02/10/2025 02/10/2032 Common Stock 2,002 $250.43 D
Stock Appreciation Right (2) 02/13/2033 Common Stock 3,433 $232.11 D
Stock Appreciation Right (3) 02/07/2034 Common Stock 3,453 $214.34 D
Stock Appreciation Right (4) 01/28/2035 Common Stock 8,778 $203.43 D
Explanation of Responses:
1. This amount includes 374 RSUs granted on February 13, 2023 which will vest on February 13, 2026 and 7,373 RSUs granted on January 28, 2025 which will vest on January 28, 2028.
2. This stock appreciation right remains outstanding under the grant; 2,288 of which are currently vested; and 1,145 of which will vest on February 13, 2026.
3. This stock appreciation right remains outstanding under the grant; 1,151 of which are currently vested; and 2,302 of which will vest in two annual installments beginning on February 7, 2026.
4. This stock appreciation right vests in three annual installments beginning on January 28, 2026.
Remarks:
EVP, AI and Technology Solutions. Power of Attorney
/s/ Matthew Gilmartin, Attorney-in Fact for Bernd Haas 01/09/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Who is the insider reporting holdings in IQVIA (IQV)?

The insider is Bernd Haas, who serves as EVP, AI and Technology Solutions at IQVIA Holdings Inc.

How many IQVIA (IQV) common shares does Bernd Haas beneficially own?

He beneficially owns 16,589 shares of IQVIA common stock, held directly, including certain restricted stock units scheduled to vest in future years.

What restricted stock units (RSUs) are included in Bernd Haas’s IQVIA holdings?

His total includes 374 RSUs granted on February 13, 2023 that vest on February 13, 2026 and 7,373 RSUs granted on January 28, 2025 that vest on January 28, 2028.

What stock appreciation rights (SARs) does Bernd Haas hold in IQVIA (IQV)?

He holds several stock appreciation rights over IQVIA common stock, with share amounts including 2,781, 1,843, 4,032, 1,869, 2,002, 3,433, 3,453, and 8,778, each with specified exercise prices and expiration dates between 2028 and 2035.

What are the exercise prices and expirations of the IQVIA stock appreciation rights held by Bernd Haas?

The stock appreciation rights have exercise prices of $95.23, $131.82, $161.70, $183.82, $250.43, $232.11, $214.34 and $203.43, with expiration dates from February 8, 2028 through January 28, 2035.

How do the vesting schedules work for Bernd Haas’s IQVIA stock appreciation rights?

Certain stock appreciation rights remain outstanding with portions already vested and the remainder vesting over time. One award has 2,288 rights currently vested and 1,145 vesting on February 13, 2026; another has 1,151 vested and 2,302 vesting in two annual installments beginning on February 7, 2026. A further award vests in three annual installments beginning on January 28, 2026.

Iqvia Hldgs Inc

NYSE:IQV

IQV Rankings

IQV Latest News

IQV Latest SEC Filings

IQV Stock Data

41.42B
168.53M
1.05%
102.1%
2.9%
Diagnostics & Research
Services-commercial Physical & Biological Research
Link
United States
DURHAM